Cargando…

China county-based prostate specific antigen screening for prostate cancer and a cost-effective analysis

BACKGROUND: Prostate cancer is one of the most common malignant tumors worldwide, and is the third-leading cause of cancer death in men. Nearly 70% of new prostate cancer patients in China are locally advanced or widely metastatic with poor prognosis. Providing active treatment to early stage prosta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhiguo, Liang, Guoshu, Zhang, Peng, Zhao, Zhongqi, He, Zhongnan, Luo, Fengzhen, Chen, Zhenqing, Yang, Zongke, Zhang, Zhijie, Xia, Tao, Liu, Xin, Zhang, Yong, Ye, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575585/ https://www.ncbi.nlm.nih.gov/pubmed/34804822 http://dx.doi.org/10.21037/tau-21-779

Ejemplares similares

Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis
por: Qin, Xiaojian, et al.
Publicado: (2021)

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
por: Heijnsdijk, E A M, et al.
Publicado: (2009)

Alarmingly High Rate of Prostate Cancer Detected by Routine Prostate-Specific Antigen Screening in a County HIV Clinic
por: Baca, Amy, et al.
Publicado: (2017)

Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China
por: Zhang, J., et al.
Publicado: (2016)

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
por: Bai, Xiaojing, et al.
Publicado: (2020)

Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer
por: Zhang, Qingxu, et al.
Publicado: (2023)

Advice About Screening for Prostate Cancer With Prostate-Specific Antigen
por: Jean-Pierre, Gannel
Publicado: (2017)

Prostate Specific Antigen, Mean Platelet Volume, and Platelet Distribution Width in Combination to Discriminate Prostate Cancer from Benign Prostate Hyperplasia
por: Fu, Shuang, et al.
Publicado: (2018)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Phage display screening identifies a prostate specific antigen (PSA)(–/lo) prostate cancer cell specific peptide to retard castration resistance of prostate cancer
por: Sui, Yi, et al.
Publicado: (2021)

Bioimpedance and chronoamperometry as an adjunct to prostate-specific antigen screening for prostate cancer
por: de Abreu, Darci Schiavon
Publicado: (2011)

Prostate cancer screening with prostate-specific antigen: A guide to the guidelines
por: Cabarkapa, Sonja, et al.
Publicado: (2016)

Gene‒Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer
por: Yang, Teng-Kai, et al.
Publicado: (2019)

Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer
por: Nyame, Yaw A, et al.
Publicado: (2020)

Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options
por: Narain, Tushar Aditya, et al.
Publicado: (2022)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Screening for prostate cancer: a study on the free and total prostate specific antigen
por: Mediu, Ridvana, et al.
Publicado: (2021)

Prostate-specific antigen screening for prostate cancer: An old but never-ending story
por: Kim, Sun Il
Publicado: (2023)

Prostate hyperplasia in St Mary's Hospital Lacor: utility of prostate specific antigen in screening for prostate malignancy
por: Okidi, Ronald, et al.
Publicado: (2020)

Multiple therapeutic and preventive effects of 3,3′-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia
por: Zhang, William Weiben, et al.
Publicado: (2014)

Adding free to total prostate-specific antigen levels in trials of prostate cancer screening
por: Wald, N J, et al.
Publicado: (2000)

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial
por: Määttänen, L, et al.
Publicado: (2007)

Is Prostate-Specific Antigen Effective for Population Screening of Prostate Cancer? A Systematic Review
por: Lee, Yoon Jae, et al.
Publicado: (2013)

Discoveries and application of prostate-specific antigen, and some proposals to optimize prostate cancer screening
por: Tokudome, Shinkan, et al.
Publicado: (2016)

Prostate-specific antigen-based screening: controversy and guidelines
por: Kim, Eric H, et al.
Publicado: (2015)

Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam
por: Wever, Elisabeth M., et al.
Publicado: (2010)

Decreasing trend in prostate cancer with high serum prostate-specific antigen levels detected at first prostate-specific antigen-based population screening in Japan
por: Kitagawa, Yasuhide, et al.
Publicado: (2014)

Spatial Analysis of Prostate Cancer in Texas Counties
por: Baniya, Ganesh, et al.
Publicado: (2020)

The influence of prostate volume on clinical parameters in prostate cancer screening
por: Shan, Jiahao, et al.
Publicado: (2022)

Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis
por: Yan, Jianzhou, et al.
Publicado: (2022)

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
por: Tikkinen, Kari A O, et al.
Publicado: (2018)

Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer
por: Heijnsdijk, Eveline A M, et al.
Publicado: (2020)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Low-Value Prostate-Specific Antigen Screening in Older Males
por: Kalavacherla, Sandhya, et al.
Publicado: (2023)

Evaluation of the Prostate Imaging Reporting and Data System for Magnetic Resonance Imaging Diagnosis of Prostate Cancer in Patients with Prostate-specific Antigen <20 ng/ml
por: Wang, Xuan, et al.
Publicado: (2016)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
por: Mikropoulos, Christos, et al.
Publicado: (2018)

Brief report: Impact of healthcare quality on prostate specific antigen screening for the early detection of prostate cancer
por: Rezaee, Michael E., et al.
Publicado: (2019)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
por: Ilic, Dragan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pglcmhsgd9bdbma91pmqef2ure